{"doi":"10.1016/j.biopsych.2013.03.002","title":"Naltrexone and Nalmefene: Any Meaningful Difference?","abstract":null,"journal":"Biological Psychiatry","year":2013,"id":29123,"datarank":1.6160946341072568,"base_score":3.4657359027997265,"endowment":3.4657359027997265,"self_citation_contribution":0.519860385419959,"citation_network_contribution":1.0962342486872978,"self_endowment_contribution":0.519860385419959,"citer_contribution":1.0962342486872978,"corpus_percentile":null,"corpus_rank":null,"citation_count":31,"citer_count":31,"citers_with_citation_signal":27,"citers_with_endowment":27,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":161326,"name":"Robert M. Swift","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.4657359027997265,"endowment":3.4657359027997265,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23540350","pmcid":null,"openalex_id":"https://openalex.org/W2148496269","authors":[],"funders":[],"total_grants":0,"fwci":2.8457,"citation_percentile":0.91020024,"influential_citations":1,"citation_trend":[{"year":2013,"count":1},{"year":2014,"count":3},{"year":2015,"count":4},{"year":2016,"count":6},{"year":2017,"count":3},{"year":2018,"count":1},{"year":2019,"count":4},{"year":2020,"count":3},{"year":2021,"count":3},{"year":2022,"count":2},{"year":2024,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0006322313001935?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0006322313001935?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.biopsych.2013.03.002","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/23540350","host_type":"repository"}],"fields_of_study":["Substance Abuse Treatment and Outcomes","Neurotransmitter Receptor Influence on Behavior","Mental Health Research Topics","Medicine","Psychology","Alcoholism","Female","Humans","Male","Naltrexone","Narcotic Antagonists","Secondary Prevention"],"mesh_terms":["Alcoholism","Female","Humans","Male","Naltrexone","Narcotic Antagonists","Secondary Prevention"],"keywords":["Nalmefene","Naltrexone","Alcohol dependence","Opioid antagonist","Placebo","Medicine","Psychosocial","Randomized controlled trial","Psychiatry","Narcotic antagonist","Relapse prevention","Alcohol","Modalities","Opioid","Psychology","Internal medicine","Alternative medicine","(+)-Naloxone"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T22:41:25.116087Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}